CDT (conduitpharma.com) Kacepetan wutah bathi saben saham ing taun lumaku

Conduit Pharmaceuticals management is implementing an innovative IDP model to accelerate the commercialization of immunological assets. The annual earnings per share growth vector visualizes the dynamics of this process, where the value of 0.00 represents the latest figure. Conduit Pharmaceuticals is developing a diversified portfolio of renal drugs, minimizing risks through licensing agreements. High capital intensity and patent protection reliably safeguard the niche from new entrants.

Wutah bathi ing taun lumaku: Conduit Pharma (CDT) kanggo 21.02.2024 - 12.11.2026

Rincian analitis lan laporan data perusahaan Conduit Pharmaceuticals (CDT)

- kuotasi lan prakiraan analis:

Kurs saham Conduit Pharmaceuticals Inc|CDT - Prakiraan konsensus analis

- indikator valuasi pasar bisnis:

Nilai pasar Conduit Therapeutics|CDT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Nilai Aset Bersih saben Saham Conduit Pharmaceuticals|CDT - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih conduitpharma.com|CDT - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Modal Conduit Pharmaceuticals|CDT - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal conduitpharma.com|CDT - Gunggung utang perusahaan|Rasio utang marang nilai buku Conduit Therapeutics|CDT - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Conduit Pharmaceuticals|Koefisien jangkoan perantara conduitpharma.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

CDT - Penghasilan resik|Bathi resik mangsa ngarep Conduit Pharmaceuticals|CDT - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Conduit Therapeutics|CDT - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Conduit Therapeutics|CDT - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Conduit Pharmaceuticals|CDT - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan conduitpharma.com|CDT - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Conduit Pharmaceuticals

Pambiji fundamental:Conduit Pharmaceuticals Inc

Produk mawa merek Conduit Pharmaceuticals Inc

Screening the dynamics of a business's net return is critical for constructing a defensive portfolio. This indicator measures the percentage change in earnings per share over twelve months, allowing for a real-time assessment of a reversal in the profitability trend. For Conduit Pharmaceuticals (CDT), comparing EPS to the same period last year reflects the monetization of inertial demand for kidney therapy, confirming the margin resilience of its patented formulas.

Pesaing wigati

Wutah bathi saben saham ing taun iki TVTX|ARDX (Ardelyx Pharma) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku ProKidney Pharma PROK|Wutah bathi resik saben saham ing taun iki AKBA (Akebia Therapeutics)|TVRD - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku DMAC (DiaMedica Therapeutics Inc.)|UNCY - Wutah bathi resik saben saham ing taun iki|RMTI - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Cadrenal Therapeutics Inc|calliditas.se (CALT) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki RNLX|ZVSA (ZyVersa Therapeutics Inc.) - Wutah bathi ing taun lumaku